It is very possible that they are marking the spot as the presentation to cancer specialists and as this study was due to conclude in April according to the study website they may be going through final process with the study regulator and may announce something between now and the conference. Yes it’s potentially wonderful news for the sufferers and in time for shareholders but tentative times. Given silence from ASX it looks like they are managing this well as the experienced team they are. So let’s watch for the next release as the details of the presentation from doctor to doctor is at a different level to a market release.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting, page-80
-
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M |
Open | High | Low | Value | Volume |
5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 348447 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 1214875 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 348447 | 0.054 |
9 | 425998 | 0.053 |
13 | 2137592 | 0.052 |
21 | 4150130 | 0.051 |
39 | 3576889 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 700000 | 4 |
0.056 | 556147 | 3 |
0.057 | 1055166 | 8 |
0.058 | 410000 | 6 |
0.059 | 292981 | 9 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |